Filing Details
- Accession Number:
- 0000950170-24-010967
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-02 21:24:58
- Reporting Period:
- 2024-01-31
- Accepted Time:
- 2024-02-02 21:24:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1593899 | Atea Pharmaceuticals Inc. | AVIR | Pharmaceutical Preparations (2834) | 460574869 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1829899 | Mj Janet Hammond | 225 Franklin Street Suite 2100 Boston MA 02110 | Chief Development Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-01-31 | 46,800 | $0.00 | 49,391 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-02-01 | 14,029 | $3.84 | 35,362 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2024-01-31 | 46,800 | $0.00 | 46,800 | $0.00 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2024-01-31 | 225,200 | $0.00 | 225,200 | $4.16 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 93,600 | No | 4 | M | Direct | ||
| 225,200 | 2034-01-30 | No | 4 | A | Direct |
Footnotes
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- Includes 2,591 additional shares acquired under the Atea Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan.
- Shares were sold solely to cover taxes upon the vesting of restricted stock units pursuant to a standing Rule 10b5-1 instruction dated March 14, 2022.
- The original grant of 140,400 RSUs vested or will vest in three (3) equal annual installments on the first three anniversaries of January 31, 2023 such that the RSUs are fully vested on January 31, 2026.
- The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2024 such that the option is fully vested on January 31, 2028.
Billionaire Hedge Funds
